Jay Newmark
Overview
Explore the profile of Jay Newmark including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
34
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Honig S, Gittelman M, Kaminetsky J, Wang C, Amory J, Rohowsky N, et al.
J Sex Med
. 2022 Oct;
19(12):1750-1758.
PMID: 36272969
Background: Long-term data evaluating the efficacy and safety of oral testosterone undecanoate (oral TU; JATENZO) in adult hypogonadal men provides important information for healthcare professionals who prescribe testosterone replacement therapy...
2.
Eggener S, Karsh L, Richardson T, Shindel A, Lu R, Rosenberg S, et al.
Urology
. 2019 Jan;
126:76-82.
PMID: 30611659
Objective: To validate the 17-gene Oncotype DX Genomic Prostate Score (GPS) biopsy-based gene expression assay as a predictor of adverse pathology (AP, Gleason score [pGS] ≥4+3and/or ≥pT3) in a prospectively...
3.
Maccini M, Westfall N, Van Bokhoven A, Lucia M, Poage W, Maroni P, et al.
Prostate
. 2018 Feb;
78(7):506-511.
PMID: 29460452
Background: The 4Kscore is a new commercially available blood-based diagnostic test which predicts risk for aggressive, clinically significant prostate cancer on prostate biopsy. The 4Kscore is currently restricted to patients...
4.
Zappala S, Dong Y, Linder V, Reeve M, Sjoberg D, Mathur V, et al.
Int J Clin Pract
. 2017 May;
71(6).
PMID: 28497893
Introduction: The 4Kscore Test is a prebiopsy blood test that incorporates four prostate protein biomarkers along with patient clinical information to determine a man's risk for high-grade, aggressive (Gleason ≥7)...